Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249

1.

Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains.

Secore S, Wang S, Doughtry J, Xie J, Miezeiewski M, Rustandi RR, Horton M, Xoconostle R, Wang B, Lancaster C, Kristopeit A, Wang SC, Christanti S, Vitelli S, Gentile MP, Goerke A, Skinner J, Strable E, Thiriot DS, Bodmer JL, Heinrichs JH.

PLoS One. 2017 Jan 26;12(1):e0170640. doi: 10.1371/journal.pone.0170640. eCollection 2017.

2.

Design and Purification of Subunit Vaccines for Prevention of Clostridium difficile Infection.

Karczewski J, Bodmer JL, Cook JC, Xoconostle RF, Nahas DD, Joyce JG, Heinrichs JH, Secore S.

Methods Mol Biol. 2016;1403:385-96. doi: 10.1007/978-1-4939-3387-7_20.

PMID:
27076142
3.

Resolution of Chlamydia trachomatis Infection Is Associated with a Distinct T Cell Response Profile.

Picard MD, Bodmer JL, Gierahn TM, Lee A, Price J, Cohane K, Clemens V, DeVault VL, Gurok G, Kohberger R, Higgins DE, Siber GR, Flechtner JB, Geisler WM.

Clin Vaccine Immunol. 2015 Nov;22(11):1206-18. doi: 10.1128/CVI.00247-15. Epub 2015 Oct 7.

4.

Large screen approaches to identify novel malaria vaccine candidates.

Davies DH, Duffy P, Bodmer JL, Felgner PL, Doolan DL.

Vaccine. 2015 Dec 22;33(52):7496-505. doi: 10.1016/j.vaccine.2015.09.059. Epub 2015 Oct 1. Review.

5.

An Exploratory Analysis of Public Awareness and Perception of Ionizing Radiation and Guide to Public Health Practice in Vermont.

Evans KM, Bodmer J, Edwards B, Levins J, O'Meara A, Ruhotina M, Smith R, Delaney T, Hoffman-Contois R, Boccuzzo L, Hales H, Carney JK.

J Environ Public Health. 2015;2015:476495. doi: 10.1155/2015/476495. Epub 2015 Apr 28.

6.

An in vitro culture model to study the dynamics of colonic microbiota in Syrian golden hamsters and their susceptibility to infection with Clostridium difficile.

Miezeiewski M, Schnaufer T, Muravsky M, Wang S, Caro-Aguilar I, Secore S, Thiriot DS, Hsu C, Rogers I, DeSantis T, Kuczynski J, Probst AJ, Chehoud C, Steger R, Warrington J, Bodmer JL, Heinrichs JH.

ISME J. 2015 Feb;9(2):321-32. doi: 10.1038/ismej.2014.127. Epub 2014 Jul 18.

7.

Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.

Karczewski J, Zorman J, Wang S, Miezeiewski M, Xie J, Soring K, Petrescu I, Rogers I, Thiriot DS, Cook JC, Chamberlin M, Xoconostle RF, Nahas DD, Joyce JG, Bodmer JL, Heinrichs JH, Secore S.

Vaccine. 2014 May 19;32(24):2812-8. doi: 10.1016/j.vaccine.2014.02.026. Epub 2014 Mar 21.

PMID:
24662701
8.

Development and optimization of a novel assay to measure neutralizing antibodies against Clostridium difficile toxins.

Xie J, Zorman J, Indrawati L, Horton M, Soring K, Antonello JM, Zhang Y, Secore S, Miezeiewski M, Wang S, Kanavage AD, Skinner JM, Rogers I, Bodmer JL, Heinrichs JH.

Clin Vaccine Immunol. 2013 Apr;20(4):517-25. doi: 10.1128/CVI.00549-12. Epub 2013 Feb 6.

9.

Rapid automation of a cell-based assay using a modular approach: case study of a flow-based Varicella Zoster Virus infectivity assay.

Joelsson D, Gates IV, Pacchione D, Wang CJ, Bennett PS, Zhang Y, McMackin J, Frey T, Brodbeck KC, Baxter H, Barmat SL, Benetti L, Bodmer JL.

J Virol Methods. 2010 Jun;166(1-2):1-11. doi: 10.1016/j.jviromet.2010.01.016. Epub 2010 Feb 1.

PMID:
20117140
10.

The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury.

Liao S, Bodmer JR, Azhar M, Newman G, Coffin JD, Doetschman T, Schultz Jel J.

J Mol Cell Cardiol. 2010 Jun;48(6):1245-54. doi: 10.1016/j.yjmcc.2010.01.014. Epub 2010 Jan 29.

11.

Quantitative measurement of varicella-zoster virus infection by semiautomated flow cytometry.

Gates IV, Zhang Y, Shambaugh C, Bauman MA, Tan C, Bodmer JL.

Appl Environ Microbiol. 2009 Apr;75(7):2027-36. doi: 10.1128/AEM.02006-08. Epub 2009 Feb 5.

12.

Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease.

Liao S, Bodmer J, Pietras D, Azhar M, Doetschman T, Schultz Jel J.

Dev Dyn. 2009 Feb;238(2):249-64. doi: 10.1002/dvdy.21677. Review.

13.

Endothelial cell electrical impedance parameter artifacts produced by a gold electrode and phase sensitive detection.

English AE, Squire JC, Bodmer JE, Moy AB.

IEEE Trans Biomed Eng. 2007 May;54(5):863-73.

PMID:
17518283
14.

Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human.

Bossen C, Ingold K, Tardivel A, Bodmer JL, Gaide O, Hertig S, Ambrose C, Tschopp J, Schneider P.

J Biol Chem. 2006 May 19;281(20):13964-71. Epub 2006 Mar 17.

15.

Envenomations.

Singletary EM, Rochman AS, Bodmer JC, Holstege CP.

Med Clin North Am. 2005 Nov;89(6):1195-224. Review.

PMID:
16227060
16.

Modeling error and stability of endothelial cytoskeletal membrane parameters based on modeling transendothelial impedance as resistor and capacitor in series.

Bodmer JE, English A, Brady M, Blackwell K, Haxhinasto K, Fotedar S, Borgman K, Bai EW, Moy AB.

Am J Physiol Cell Physiol. 2005 Sep;289(3):C735-47. Epub 2005 May 4.

17.
18.

Gene delivery of l-caldesmon protects cytoskeletal cell membrane integrity against adenovirus infection independently of myosin ATPase and actin assembly.

Haxhinasto K, Kamath A, Blackwell K, Bodmer J, Van Heukelom J, English A, Bai EW, Moy AB.

Am J Physiol Cell Physiol. 2004 Oct;287(4):C1125-38. Epub 2004 Jun 9.

19.
20.

Phorbol ester-mediated pulmonary artery endothelial barrier dysfunction through regulation of actin cytoskeletal mechanics.

Moy AB, Blackwell K, Wang N, Haxhinasto K, Kasiske MK, Bodmer J, Reyes G, English A.

Am J Physiol Lung Cell Mol Physiol. 2004 Jul;287(1):L153-67. Epub 2004 Mar 5.

21.

Identification of a basic surface area of the FADD death effector domain critical for apoptotic signaling.

Kaufmann M, Bozic D, Briand C, Bodmer JL, Zerbe O, Kohl A, Tschopp J, Grütter MG.

FEBS Lett. 2002 Sep 11;527(1-3):250-4.

22.

Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells.

Hopkins-Donaldson S, Yan P, Bourloud KB, Muhlethaler A, Bodmer JL, Gross N.

Oncogene. 2002 Sep 5;21(39):6132-7.

23.

The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination and repair.

Hopfner KP, Craig L, Moncalian G, Zinkel RA, Usui T, Owen BA, Karcher A, Henderson B, Bodmer JL, McMurray CT, Carney JP, Petrini JH, Tainer JA.

Nature. 2002 Aug 1;418(6897):562-6.

PMID:
12152085
24.

Overexpression of Helicard, a CARD-containing helicase cleaved during apoptosis, accelerates DNA degradation.

Kovacsovics M, Martinon F, Micheau O, Bodmer JL, Hofmann K, Tschopp J.

Curr Biol. 2002 May 14;12(10):838-43. Erratum in: Curr Biol. 2002 Sep 17;12(18):1633..

25.

A human genome diversity cell line panel.

Cann HM, de Toma C, Cazes L, Legrand MF, Morel V, Piouffre L, Bodmer J, Bodmer WF, Bonne-Tamir B, Cambon-Thomsen A, Chen Z, Chu J, Carcassi C, Contu L, Du R, Excoffier L, Ferrara GB, Friedlaender JS, Groot H, Gurwitz D, Jenkins T, Herrera RJ, Huang X, Kidd J, Kidd KK, Langaney A, Lin AA, Mehdi SQ, Parham P, Piazza A, Pistillo MP, Qian Y, Shu Q, Xu J, Zhu S, Weber JL, Greely HT, Feldman MW, Thomas G, Dausset J, Cavalli-Sforza LL.

Science. 2002 Apr 12;296(5566):261-2. No abstract available.

PMID:
11954565
26.

The molecular architecture of the TNF superfamily.

Bodmer JL, Schneider P, Tschopp J.

Trends Biochem Sci. 2002 Jan;27(1):19-26. Review.

PMID:
11796220
27.

Nomenclature for factors of the HLA system, 2000.

Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, MacH B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Eur J Immunogenet. 2001 Jun;28(3):377-424. No abstract available.

PMID:
11422419
28.

Nomenclature for factors of the HLA system, 2000.

Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Hum Immunol. 2001 Apr;62(4):419-68. No abstract available.

PMID:
11295476
29.

Nomenclature for factors of the HLA system, 2000.

Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Tissue Antigens. 2001 Mar;57(3):236-83. No abstract available.

PMID:
11285132
30.

Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.

Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J.

Nat Immunol. 2000 Dec;1(6):489-95.

PMID:
11101870
31.

HLA class I in three West African ethnic groups: genetic distances from sub-Saharan and Caucasoid populations.

Modiano D, Luoni G, Petrarca V, Sodiomon Sirima B, De Luca M, Simporé J, Coluzzi M, Bodmer JG, Modiano G.

Tissue Antigens. 2001 Feb;57(2):128-37.

PMID:
11260507
32.

Alkaline-mediated differential interaction (AMDI): a simple automatable single-nucleotide polymorphism assay.

Bartlett S, Straub J, Tonks S, Wells RS, Bodmer JG, Bodmer WF.

Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2694-7. Epub 2001 Feb 20.

33.

Loss of caspase-8 expression in neuroblastoma is related to malignancy and resistance to TRAIL-induced apoptosis.

Hopkins-Donaldson S, Bodmer JL, Bourloud KB, Brognara CB, Tschopp J, Gross N.

Med Pediatr Oncol. 2000 Dec;35(6):608-11.

PMID:
11107128
34.

Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3).

Kaptein A, Jansen M, Dilaver G, Kitson J, Dash L, Wang E, Owen MJ, Bodmer JL, Tschopp J, Farrow SN.

FEBS Lett. 2000 Nov 24;485(2-3):135-41.

35.

Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2.

Benedict CA, Norris PS, Prigozy TI, Bodmer JL, Mahr JA, Garnett CT, Martinon F, Tschopp J, Gooding LR, Ware CF.

J Biol Chem. 2001 Feb 2;276(5):3270-8. Epub 2000 Oct 24.

36.
37.

The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation.

Mühlenbeck F, Schneider P, Bodmer JL, Schwenzer R, Hauser A, Schubert G, Scheurich P, Moosmayer D, Tschopp J, Wajant H.

J Biol Chem. 2000 Oct 13;275(41):32208-13.

38.

TRAIL receptor-2 signals apoptosis through FADD and caspase-8.

Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P, Blenis J, Tschopp J.

Nat Cell Biol. 2000 Apr;2(4):241-3. No abstract available.

PMID:
10783243
39.

IMGT/HLA database--a sequence database for the human major histocompatibility complex.

Robinson J, Malik A, Parham P, Bodmer JG, Marsh SG.

Tissue Antigens. 2000 Mar;55(3):280-7.

PMID:
10777106
40.

Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL.

Bodmer JL, Meier P, Tschopp J, Schneider P.

J Biol Chem. 2000 Jul 7;275(27):20632-7.

41.

Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors.

Holler N, Kataoka T, Bodmer JL, Romero P, Romero J, Deperthes D, Engel J, Tschopp J, Schneider P.

J Immunol Methods. 2000 Apr 3;237(1-2):159-73.

PMID:
10725460
42.
43.

Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours.

Rapley EA, Crockford GP, Teare D, Biggs P, Seal S, Barfoot R, Edwards S, Hamoudi R, Heimdal K, Fossâ SD, Tucker K, Donald J, Collins F, Friedlander M, Hogg D, Goss P, Heidenreich A, Ormiston W, Daly PA, Forman D, Oliver TD, Leahy M, Huddart R, Cooper CS, Bodmer JG, Easton DF, Stratton MR, Bishop DT.

Nat Genet. 2000 Feb;24(2):197-200.

PMID:
10655070
44.

IMGT/HLA Database--a sequence database for the human major histocompatibility complex.

Robinson J, Waller MJ, Parham P, Bodmer JG, Marsh SG.

Nucleic Acids Res. 2001 Jan 1;29(1):210-3.

45.

IMGT, the international ImMunoGeneTics database.

Ruiz M, Giudicelli V, Ginestoux C, Stoehr P, Robinson J, Bodmer J, Marsh SG, Bontrop R, Lemaitre M, Lefranc G, Chaume D, Lefranc MP.

Nucleic Acids Res. 2000 Jan 1;28(1):219-21.

46.

Nomenclature for factors of the HLA system, 1998.

Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Vox Sang. 1999;77(3):164-91. No abstract available.

PMID:
10545854
47.

Rose Payne 1909-1999. With personal recollections by Julia and Walter Bodmer.

Bodmer J, Bodmer W.

Tissue Antigens. 1999 Jul;54(1):102-5. No abstract available.

PMID:
10458330
48.

Cyclic adenosine monophosphate protects endothelial barrier function independent of inhibiting 20-kd myosin light chain-dependent tension development.

Moy AB, Bodmer JE, Blackwell K, Shasby S, Kamath A, Shasby DM.

Chest. 1999 Jul;116(1 Suppl):33S. No abstract available.

PMID:
10424579
49.

IMGT, the international ImMunoGeneTics database: a new design for immunogenetics data access.

Giudicelli V, Chaume D, Mennessier G, Althaus HH, Müller W, Bodmer J, Malik A, Lefranc MP.

Stud Health Technol Inform. 1998;52 Pt 1:351-5.

PMID:
10384476
50.

Nomenclature for factors of the HLA System, 1998.

Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Hum Immunol. 1999 Apr;60(4):361-95. No abstract available.

PMID:
10363728

Supplemental Content

Loading ...
Support Center